Register Free at
www.pharmtech.com/highpotency
Event Overview:
With the increasing use of high-potency APIs, containment strategies are becoming increasingly important. Systems must be designed to both protect safety of the workers and safety of the drug products. Applying a science- and risk-based approach to mitigate cross-contamination and ensure proper segregation of facilities and operations is crucial. This 30-minute webinar will focus on current best practices and strategies for containment in high-potency manufacturing.
Key Learning Objectives:
- Learn how to optimize containment in high-potency manufacturing
- Learn best practices to ensure operator safety
- Discuss best practices and various risk-mitigation strategies, including the use of disposables.
- Understand regulatory and industry guidance for high-potency manufacturing
For questions contact Sara Barschdorf at sbarschdorf@advanstar.com
|
 |
Who Should Attend: |
- Director, group leader, manager, senior scientist in QA/QC
- Director, group leader, manager of regulatory affairs
- Director, group leader, manager, senior personnel of manufacturing
- Director, group leader, manager, senior scientist in analytical development
|
Presenters: |

|
John P. Farris, CIH
President & CEO
SafeBridge Consultants, Inc. |
Moderator: |
Jennifer Markarian
Manufacturing Editor
Pharmaceutical Technology |
|